Amarin Corporation
AMRN
#8098
Rank
A$0.47 B
Marketcap
A$22.85
Share price
1.65%
Change (1 day)
17.47%
Change (1 year)

Earnings for Amarin Corporation (AMRN)

Earnings in 2025 (TTM): -A$0.14 Billion

According to Amarin Corporation 's latest financial reports the company's current earnings are A$0.22 Billion. In 2024 the company made an earning of -A$0.12 Billion a decrease over its 2023 earnings that were of -A$76.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amarin Corporation from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.14 Billion22.5%
2024 -A$0.12 Billion43.84%
2023 -A$76.51 Million-48.3%
2022 -A$0.15 Billion-1019.36%
2021 A$16.09 M-165.44%
2020 -A$24.6 Million-23.25%
2019 -A$32.05 Million-80.68%
2018 -A$0.17 Billion112.25%
2017 -A$78.14 Million-28.23%
2016 -A$0.11 Billion-35.43%
2015 -A$0.17 Billion99.81%
2014 -A$84.39 Million-65.06%
2013 -A$0.25 Billion-0.38%
2012 -A$0.25 Billion-150.87%
2011 A$0.47 B-233.68%
2010 -A$0.36 Billion
2007 -A$55.64 Million44.04%
2006 -A$38.63 Million
2004 -A$20.88 Million-46.41%
2003 -A$38.95 Million-41.09%
2002 -A$66.11 Million813.31%
2001 -A$7.24 Million113.63%
2000 -A$3.39 Million
1998 -A$24.09 Million98.82%
1997 -A$12.12 Million-50.29%
1996 -A$24.38 Million-1321.43%
1995 A$1.99 M-94.53%
1994 A$36.49 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
A$9.40 B-7,851.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.90 B-17,331.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.27 B-11,864.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
A$0.33 B-378.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$3.23 B-2,768.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel